BioLife Solutions BLFS Europe, Middle East, Africa (EMEA) — Concentration risk (in percent)
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by BioLife Solutions in its filing.
Tagged under the XBRL concept us-gaap:ConcentrationRiskPercentage1.
The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioLife Solutions's europe, middle east, africa (emea) — concentration risk (in percent).
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioLife Solutions's europe, middle east, africa (EMEA) — concentration risk (in percent)?
- BioLife Solutions (BLFS) reported europe, middle east, africa (EMEA) — concentration risk (in percent) of 14% in Q1 2026.
- How has BioLife Solutions's europe, middle east, africa (EMEA) — concentration risk (in percent) changed year-over-year?
- BioLife Solutions's europe, middle east, africa (EMEA) — concentration risk (in percent) decreased by 6.7% year-over-year, from 15% to 14%.
- What does europe, middle east, africa (EMEA) — concentration risk (in percent) mean?
- This metric measures the proportion of total segment revenue derived from the largest single customer or a small group of key customers within the EMEA region. It serves as a critical indicator of revenue dependency and potential vulnerability to the loss of major accounts in this geographic market. High concentration levels suggest increased business risk, as the segment's financial performance is heavily tied to the procurement decisions of a limited set of clients.